Primary biliary cirrhosis. [N Engl J Med. 2005] - PubMed

loading

Primary biliary cirrhosis. [N Engl J Med. 2005]
Primary biliary cirrhosis.
Gong Y, Christensen E, Gluud C. N Engl J Med. 2005 Dec 22; 353(25):2719-20; author reply 2719-20.
Review The use of methotrexate, colchicine, and other immunomodulatory drugs in the treatment of primary biliary cirrhosis. [Semin Liver Dis. 1997]
Review The use of methotrexate, colchicine, and other immunomodulatory drugs in the treatment of primary biliary cirrhosis.
Kaplan MM. Semin Liver Dis. 1997 May; 17(2):129-36.
Review [Cholestatic liver diseases: diagnosis and therapy of primary biliary cirrhosis]. [Dtsch Med Wochenschr. 2002]
Review [Cholestatic liver diseases: diagnosis and therapy of primary biliary cirrhosis].
Thimme R, Opitz OG, Kreisel W. Dtsch Med Wochenschr. 2002 Sep 6; 127(36):1823-6.
Review [Primary biliary cirrhosis--antimitochondrial antibody and the reactive antigens]. [Fukuoka Igaku Zasshi. 1995]
Review [Primary biliary cirrhosis--antimitochondrial antibody and the reactive antigens].
Ishibashi H. Fukuoka Igaku Zasshi. 1995 Oct; 86(10):385-8.
[Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard]. [MMW Fortschr Med. 2007]
[Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].
Stiefelhagen P. MMW Fortschr Med. 2007 May 24; 149(21):49.

TRAF1-C5 Affects Quality of Life in Patients with Primary Biliary Cirrhosis. [Clin Dev Immunol. 2013]
TRAF1-C5 Affects Quality of Life in Patients with Primary Biliary Cirrhosis.
Raszeja-Wyszomirska J, Wunsch E, Kempinska-Podhorodecka A, Smyk DS, Bogdanos DP, Milkiewicz M, Milkiewicz P. Clin Dev Immunol. 2013; 2013:510547. Epub 2013 Apr 28.
A case of primary biliary cirrhosis that progressed rapidly after treatment involving rituximab. [Case Rep Gastroenterol. 2013]
A case of primary biliary cirrhosis that progressed rapidly after treatment involving rituximab.
Tajiri K, Tsuneyama K, Miyazono T, Kawai K, Minemura M, Sugiyama T. Case Rep Gastroenterol. 2013 Jan; 7(1):195-201. Epub 2013 Apr 19.
Risk factors for hepatic decompensation in patients with primary biliary cirrhosis. [World J Gastroenterol. 2013]
Risk factors for hepatic decompensation in patients with primary biliary cirrhosis.
Shi TY, Zhang LN, Chen H, Wang L, Shen M, Zhang X, Zhang FC. World J Gastroenterol. 2013 Feb 21; 19(7):1111-8.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Primary biliary cirrhosis.
Primary biliary cirrhosis.
N Engl J Med. 2005 Sep 22 ;353(12):1261-73.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed